Aripiprazole

Indication

Bipolar disorder in Adolescents (NICE TA292)

NICE TA 292 - Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorder

Red

Brand:

Abilify®

Nice TA:

Commissioning responsibility:

CCG

PbR excluded:

BNF chapter:

Central nervous system

Background

Aripiprazole is recommended as an option for treating moderate to severe manic episodes in adolescents with bipolar I disorder, within its marketing authorisation (that is, up to 12 weeks of treatment for moderate to severe manic episodes in bipolar I disorder in adolescents aged 13 and older)

Recommendation

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Supporting documents:

Decisions of Lancashire local decision making groups

BwD	BP	CSR	EL	FW	GP	MB	WL
Pending	Red	Red	Pending	Red	Red	Amber 1	Red

What do the colours mean?

Last Updated: 01 - Oct - 2013